<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We tested blood samples of 25 pediatric renal transplant recipients for Epstein-Barr virus (EBV) DNA load by quantitative polymerase chain reaction (PCR) </plain></SENT>
<SENT sid="1" pm="."><plain>Eleven of these transplant recipients showed clinical persistent <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">mononucleosis</z:e>-like symptoms years after transplantation (Tx) </plain></SENT>
<SENT sid="2" pm="."><plain>A quantitation of EBV DNA by PCR in peripheral blood lymphocyte (PBL) and serum samples revealed variable EBV DNA titers </plain></SENT>
<SENT sid="3" pm="."><plain>The majority of EBV PCR results in samples of the 14 asymptomatic transplant recipients was repeatedly below detection limit </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, patients with <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">mononucleosis</z:e>-like symptoms showed persistent EBV genome titers over a period of 6 months, ranging from 75 to 18 750 copies/10 000 PBL and from 680 to 335 000 copies/mL serum, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>One child suffering from this <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">mononucleosis</z:e>-like condition developed an EBV-associated Burkitt-like <z:hpo ids='HP_0002665'>lymphoma</z:hpo> 29 months after Tx </plain></SENT>
<SENT sid="6" pm="."><plain>Whereas clinical and histological investigations did not indicate a post-transplant <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo> (PTLD) until <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> detection, EBV titers in PBL and serum had been high for at least 8 months </plain></SENT>
<SENT sid="7" pm="."><plain>We propose that pediatric transplant recipients who show both, recurrent <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">mononucleosis</z:e>-like symptoms and a sustained high EBV genome load, are at increased risk for severe EBV-related post-transplant complications </plain></SENT>
</text></document>